Germline MLH1 and MSH2 PV carriers have significantly higher lifetime cancer risks for any LS associated cancers compared to carriers of MSH6 and PMS2 variants, reflecting functional redundancy of MSH6 and PMS2 [19,20]. This evidence concerns the gene PMS2 and cancer.